Siegfried Holding
Ajayi David Akinwale possesses extensive experience in the pharmaceutical industry, holding various roles that emphasize quality assurance, process engineering, and pharmaceutical science. Currently serving as a Quality Assurance Analyst at Siegfried Holding AG since August 2021, Ajayi has also worked as a Graduate Assistant in Pharmaceutical Science at Chapman University since August 2017 and as an Associate Process Engineer at Par Pharmaceutical/Endopharma since June 2018. Previous roles include Industrial Pharmaceutical Scientist at Chapman University and EMZOR Pharmaceutical Industries Limited as a Production Manager, where responsibilities encompassed pharmaceutical operations management, compounding, and formulation. Ajayi holds a Master of Pharmaceutical Science in Biopharmaceutical Science from Chapman University, an MBA in International Business from Lagos State University, and a Bachelor of Pharmacy from the University of Ibadan.
This person is not in any offices
Siegfried Holding
1 followers
Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.